When.com Web Search

  1. Ads

    related to: daratumumab long term side effects

Search results

  1. Results From The WOW.Com Content Network
  2. Daratumumab - Wikipedia

    en.wikipedia.org/wiki/Daratumumab

    Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. It binds to CD38 , [ 7 ] which is overexpressed in multiple myeloma cells. [ 8 ]

  3. Daratumumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Daratumumab/hyaluronidase

    It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]

  4. List of long term side effects of antipsychotics - Wikipedia

    en.wikipedia.org/wiki/List_of_long_term_side...

    Many patients will not develop these side effects, although there is still a significant possibility of risks associated with Antipsychotic usage. The percentage of patients affected by side effects like Tardive dyskinesia is significantly high and estimated to be a 20-50% prevalence. [1] [2]

  5. Serious Ozempic Side Effects, Confirmed: Here’s What to Know

    www.aol.com/serious-ozempic-side-effects...

    A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's what a doctor wants you to know.

  6. 6 Things to Do When You Wake Up If You Have Chronic ...

    www.aol.com/6-things-wake-chronic-inflammation...

    Common symptoms of chronic inflammation include fatigue, joint or muscle pain, long-lasting digestive issues, brain fog or difficulty concentrating, skin problems (like eczema or acne) and ...

  7. Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of ...

    lite.aol.com/tech/story/0022/20240812/9203572.htm

    After daratumumab treatment, both patients showed stabilization of kidney function parameters and a steep decline in dd-cfDNA levels below the clinical threshold for rejection. Biopsies six months after treatment demonstrated complete histologic resolution of AMR activity in one patient and partial resolution in the other.

  1. Ads

    related to: daratumumab long term side effects